Safety and Efficacy Study of BMS-908662 Alone or in Combination With Cetuximab in Subjects With K-RAS or B-RAF Mutation Positive Advanced or Metastatic Colorectal Cancer
Clinical trial NCT01086267 · COMPLETED
Trial details
- NCT number
- NCT01086267
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2011-08-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.